Priority Setting for Comparative Effectiveness Research
•
1 like•184 views
The document describes a process used by the Center for Medical Technology Policy (CMTP) to prioritize topics for comparative effectiveness research on cardiac technologies. CMTP first identified a broad list of emerging cardiac technologies and refined it to a top ten list. An expert workgroup then ranked these technologies using pre-defined criteria. The workgroup identified genetic tests for warfarin dosing, catheter ablation for atrial fibrillation, and percutaneous aortic valve replacement as the top priorities for coverage with evidence development initiatives and comparative effectiveness research studies.
Report
Share
Report
Share
![Priority-setting for comparative effectiveness research. Seidenfeld JD 1 , Montgomery RW 1 , Sonnad SS 1,2 1 Center for Medical Technology Policy, Baltimore, MD, USA, 2 Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA, USA Research Objectives Coincident with the increasing focus on comparative effectiveness research (CER) in the health research community, a number of organizations have begun to engage in prioritizing topics for CER. This poster presents the priority-setting process developed by the Center for Medical Technology Policy (CMTP) and its application to the selection of cardiac technologies. Methods (con’t) After internally refining a broad list of emerging cardiac technologies to a top ten list, we convened an expert workgroup charged with ranking these top technologies using prospectively developed criteria. Experts were provided with a list of criteria and briefs summarizing clinical, economic and ethical aspects of each technology, and then asked to evaluate each topic using a survey tool. After initial ranking, workgroup members met in person to discuss results, any remaining questions, and come to consensus on a prioritized list of final recommendations. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Horizon Scanning Topic Nomination Expert solicitation Topic selection Criteria application Discussion After reviewing background information provided by CMTP, the workgroup completed a web-based survey tool to assess each technology based upon CMTP's priority setting criteria. The workgroup met in-person for a final round of topic prioritization to discuss the background information, ask questions of CMTP staff, and bring in outside information and personal knowledge. Final Ranking ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],At the end of the meeting, participants were asked to produce lists of their preferred topics for various CMTP projects. Follow up conference call to present final rankings, gauge the degree of group consensus, and address lingering concerns and questions CMTP’s criteria for priority-setting For All Projects Coverage with Evidence Development (CED) Clinical impact Timeliness/ Potential for unregulated diffusion Economic impact Value of information Disease burden/patient population Multiple comparators Insufficient or conflicting clinical evidence Non-life threatening disease condition Improvability of evidence High pressure on payers for coverage FDA approved technologies exist Secondary considerations Guidelines for the design of new CER studies High risk of waiting No consensus on research methodology Political/operational feasibility Long-term active clinical development CMTP’s Top 10 Cardiac Technologies 1. Catheter-based ablation for the treatment of atrial fibrillation 2. Pharmacogenetic testing for estimating initial warfarin doses 3. Percutaneous aortic valve replacement (AVR) 4. Percutaneous mitral valve replacement (MVR) 5. Ultrasound for abdominal aortic aneurysm (AAA) 6. Biodegradable coronary stents 7. Autologous stem cell transplantation for acute myocardial infarction 8. DNA-based tests for risk of myocardial infarction 9. Total artificial heart 10. C-reactive protein tests](https://image.slidesharecdn.com/sonnadseema-prioritysettingforcomparativeeffectivenessresearch-100819084337-phpapp02/85/Priority-Setting-for-Comparative-Effectiveness-Research-1-320.jpg)
Recommended
Emerging diagnostic technologies proving the clinical application through g...
Next Generation Sequencing is an exciting new technology for diagnostics companies. But is it right for all products and for all companies? This presentation was delivered via Webinar for a IVD audience for Q1 Productions, March 25, 2014.
OTC Electronic Clinical Trial Recruitment
The document discusses an electronic clinical trial recruitment system that aims to address the problems of slow clinical research translation, labor-intensive and costly trial recruitment methods. It presents a solution of leveraging existing electronic medical record data across different healthcare systems and practices to more efficiently identify and enroll qualified patients for clinical trials in a networked system. The system could benefit research sponsors, investigators, medical practices, and patients by speeding recruitment times and lowering costs while improving clinical care engagement and outcomes. It analyzes the potential market opportunity and differentiation of this federated network approach to electronic clinical trial recruitment.
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...Leonard Davis Institute of Health Economics
The document discusses developing a pilot project for coverage with evidence development (CED) in the private sector. A stakeholder workgroup selected pharmacogenetic testing for estimating initial warfarin dosing as the topic. The workgroup discussed operational and study design issues, such as coverage models, communication with patients and providers, funding, and informed consent. Conducting private sector CED poses challenges but payers remain interested to generate better information for coverage decisions through this mechanism.Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
The survey found that the most significant barrier to clinical trial recruitment according to stakeholders was finding patients who meet eligibility criteria. The next most significant barriers were insufficient staff time for recruitment activities, followed by the length and complexity of consent forms, and protocol requirements other than eligibility criteria. Suggestions to overcome barriers included broadening eligibility criteria, improving planning, using effective recruitment methods and technology, simplifying processes, and improving staff support. Most stakeholders were optimistic that national recruitment rates would increase over the next 5-10 years if effective partnerships were formed between sectors like patient advocates, researchers, sponsors, and regulators.
AHRQ’s Effective Health Care Program
- The document discusses the topic selection process for the AHRQ Effective Health Care Program, which systematically reviews evidence on healthcare topics.
- It outlines principles for topic selection including stakeholder involvement, defined criteria, transparency, and process evaluation.
- An internal group reviews topic nominations using 18 selection criteria to identify important research topics in a structured, transparent manner. The process aims to prioritize topics that are relevant, non-redundant, and have sufficient evidence for review.
- Early results of the revised 2008 nomination process and ongoing challenges in identifying and prioritizing review topics are presented.
Apr 13 improving methods and processes codependent techs mg
The document summarizes Martina Garau's presentation on assessing the value of co-dependent technologies such as diagnostic tests and treatments. It discusses how co-dependent technologies can create additional value dimensions beyond traditional cost-effectiveness analysis, challenges to valuing and proving the benefits of these technologies, and examples from countries like Australia and the UK. The presentation analyzes frameworks for capturing different value elements, barriers to evidence generation, and proposes processes for jointly assessing diagnostics and treatments.
Developing the Reimbursement Story 2016-03-10
The document discusses strategies for developing a reimbursement case for molecular diagnostic tests early in development. It emphasizes designing analytic and clinical validity studies to demonstrate test accuracy and association with clinical conditions. Clinical utility studies should show how test results impact patient management, outcomes, and healthcare costs. Randomized controlled trials provide the strongest evidence but alternative study designs like prospective observational studies and decision modeling may also support reimbursement. The goal is to generate evidence of a test's medical necessity from the intended patient population to achieve coverage and payment.
CROs Driving Changes in Patient Recruitment
The CenterWatch Monthly (September 2014)
Data and tech-aided enrollment services a competitive advantage
Recommended
Emerging diagnostic technologies proving the clinical application through g...
Next Generation Sequencing is an exciting new technology for diagnostics companies. But is it right for all products and for all companies? This presentation was delivered via Webinar for a IVD audience for Q1 Productions, March 25, 2014.
OTC Electronic Clinical Trial Recruitment
The document discusses an electronic clinical trial recruitment system that aims to address the problems of slow clinical research translation, labor-intensive and costly trial recruitment methods. It presents a solution of leveraging existing electronic medical record data across different healthcare systems and practices to more efficiently identify and enroll qualified patients for clinical trials in a networked system. The system could benefit research sponsors, investigators, medical practices, and patients by speeding recruitment times and lowering costs while improving clinical care engagement and outcomes. It analyzes the potential market opportunity and differentiation of this federated network approach to electronic clinical trial recruitment.
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...
Developing a Pilot Project for Private Sector Coverage with Evidence Developm...Leonard Davis Institute of Health Economics
The document discusses developing a pilot project for coverage with evidence development (CED) in the private sector. A stakeholder workgroup selected pharmacogenetic testing for estimating initial warfarin dosing as the topic. The workgroup discussed operational and study design issues, such as coverage models, communication with patients and providers, funding, and informed consent. Conducting private sector CED poses challenges but payers remain interested to generate better information for coverage decisions through this mechanism.Results of an Online Survey of Stakeholders Regarding Barriers and Solutions ...
The survey found that the most significant barrier to clinical trial recruitment according to stakeholders was finding patients who meet eligibility criteria. The next most significant barriers were insufficient staff time for recruitment activities, followed by the length and complexity of consent forms, and protocol requirements other than eligibility criteria. Suggestions to overcome barriers included broadening eligibility criteria, improving planning, using effective recruitment methods and technology, simplifying processes, and improving staff support. Most stakeholders were optimistic that national recruitment rates would increase over the next 5-10 years if effective partnerships were formed between sectors like patient advocates, researchers, sponsors, and regulators.
AHRQ’s Effective Health Care Program
- The document discusses the topic selection process for the AHRQ Effective Health Care Program, which systematically reviews evidence on healthcare topics.
- It outlines principles for topic selection including stakeholder involvement, defined criteria, transparency, and process evaluation.
- An internal group reviews topic nominations using 18 selection criteria to identify important research topics in a structured, transparent manner. The process aims to prioritize topics that are relevant, non-redundant, and have sufficient evidence for review.
- Early results of the revised 2008 nomination process and ongoing challenges in identifying and prioritizing review topics are presented.
Apr 13 improving methods and processes codependent techs mg
The document summarizes Martina Garau's presentation on assessing the value of co-dependent technologies such as diagnostic tests and treatments. It discusses how co-dependent technologies can create additional value dimensions beyond traditional cost-effectiveness analysis, challenges to valuing and proving the benefits of these technologies, and examples from countries like Australia and the UK. The presentation analyzes frameworks for capturing different value elements, barriers to evidence generation, and proposes processes for jointly assessing diagnostics and treatments.
Developing the Reimbursement Story 2016-03-10
The document discusses strategies for developing a reimbursement case for molecular diagnostic tests early in development. It emphasizes designing analytic and clinical validity studies to demonstrate test accuracy and association with clinical conditions. Clinical utility studies should show how test results impact patient management, outcomes, and healthcare costs. Randomized controlled trials provide the strongest evidence but alternative study designs like prospective observational studies and decision modeling may also support reimbursement. The goal is to generate evidence of a test's medical necessity from the intended patient population to achieve coverage and payment.
CROs Driving Changes in Patient Recruitment
The CenterWatch Monthly (September 2014)
Data and tech-aided enrollment services a competitive advantage
Improving Methods and Processes for Assessing Codependent Technologies
Technologies that enhance the precision and effect of therapies can make a critical contribution to ensuring value for money and improving patient care. Methods and processes for assessing value, however, still are imperfect. This presentation reviews the challenges and identifies some approaches for meeting them.
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Solid protocol design is critical to clinical development. No matter how well executed a clinical study is, if the underlying design is flawed, it wasn’t worth doing. In this presentation, Dr. David Shoemaker, SVP R&D, and Dr. Karen Kesler, AVP Operations, will walk through the process of developing a protocol, explain the major considerations, and point out common mistakes and challenges.
Regulation reimbursement and evidence on NMT
This document discusses regulatory approval and reimbursement for new medical technologies. It notes challenges with rising costs and uncertainty of drug development. It describes expedited FDA pathways like Fast Track, Priority Review, and Breakthrough Therapy Designation. While approval and coverage don't always align, experiences with parallel FDA/CMS review and conditional approvals in Europe aim to better link evidence standards. Adaptive pathways could approve technologies for narrow uses with commitments for further study. The goal is improving development efficiency and patients' access to promising new options.
One size does not fit all unique study management challenges for diagnostic ...
When partnering with a CRO, diagnostic company needs are different from those of pharmaceutical and device companies. This presentation was delivered at Outsourcing in Clinical Trials West Coast 2015, February 3-4, Burlingame, California.
Secondary Evidence Based Medicine Rsources SC
This document provides information on secondary evidence-based medicine (EBM) resources and point-of-care tools. It discusses the hierarchy of levels of evidence and describes various pre-appraised systematic reviews and individual studies. Examples of highly referenced EBM textbooks and primary literature databases are given. Point-of-care resources and tools that can be used immediately with patients, such as EBM summaries and clinical decision support systems, are also described. Examples of specific point-of-care resources covering areas like systematic reviews, clinical pathways, calculators, and patient education materials are provided.
Dr. Davy Cheng
This document discusses strategies and best practices for adopting medical technology. It emphasizes the importance of health technology assessment (HTA) and knowledge translation (KT) in facilitating evidence-informed decision making. Key challenges include gaps between research evidence and clinical practice. Strategies proposed include creating timely evidence reviews, using frameworks like Know4Go to evaluate technologies based on criteria like effectiveness and costs, and developing institutional capacity for HTA-informed decisions. Local contextualization, collaboration, training, and clinician champions are seen as important for successful technology adoption.
Major healthcare delivery trends 2015
The document discusses several secular trends in healthcare, including the shift towards value-based reimbursement models, increasing consumerism, and rapid advancements in technology and use of big data. Major trends include growing consolidation across healthcare sectors, 50% of Medicare payments transitioning to value-based models by 2018, a large increase in high deductible health plans, and billions in investments in digital health, technology, and analytics.
Clinical trial recruitment overview
- Patient recruitment for clinical trials is a major challenge, estimated to be a $1.2-1.8 billion market. Recruitment costs average 6% of trial costs and are a primary factor in delays.
- Less than 5% of patients are aware of clinical trials, and only 2-3% actually enroll. However, over 90% of participants have a positive experience and would participate again.
- There is significant opportunity to improve recruitment through more patient-centric approaches leveraging data, technology, and analytics to identify more eligible patients and improve the recruitment process. However, this will require changes to traditional models.
Patient recruitment
Patient recruitment and retention in clinical trials is recognized as a major challenge. Over 80% of trials fail to enroll on time due to difficulties recruiting the required number of suitable patients. Recruitment strategies are often not considered early enough in the trial planning process. Effective recruitment requires realistic timelines, adequate budgets, and the use of multiple recruitment methods like investigator databases, clinician referrals, advertisements, and community outreach. Maintaining open communication with patients and providing convenience are important for retention. Recent approaches to improve recruitment include using professional recruitment providers, market research, informatics, and centralized recruiting systems.
In with the old, out with the new
‘In with the old, out with the new’ – In search of ways to help health economists break their addiction to technology adoption. CHE Seminar presented by Professor Stirling Bryan, Director, Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Professor, School of Population & Public Health, University of British Columbia. 17th October 2014
Patient Recruitment Insights
A presentation showcasing some of the patient recruitment challenges that I encountered as a recruitment manager as well as some of the strategies -- DIGITAL ADVERTISING -- I used to overcome them.
Knowledge transfer, and evidence informed health policy-minster's meeting
This document discusses knowledge transfer between researchers and policymakers. It begins with an overview of the knowledge cycle and evidence-based healthcare. It notes that while researchers seek truth and policymakers seek compromise, their common goal is improving public health. The document recommends establishing units to facilitate knowledge transfer and decision support. It also suggests training policymakers to identify how research can help and accessing evidence to inform decisions. The overall message is that researchers and policymakers must understand each other and work together toward their shared goal of improving health outcomes.
Clinical Trial Recruitment & Retention
Patient recruitment & retention is highlighted as the key factor in ensuring study success, the area of patient retention in clinical trials is often overlooked. Retention of patients throughout the life of a clinical trial is however extremely vital from scientific as well as economic point of view. Poor recruitment & retention negatively impacts on the overall evaluable data for regulatory submissions. Dropped participants must be replaced which incurs further expenditures and time delays. Subject dropout rates are estimated to range from 15-40% of enrolled participants in clinical trials.
1-Halt-it Protocol International v1.0 26nov12
This document outlines the protocol for the HALT-IT clinical trial, which will determine the effects of tranexamic acid (TXA) on mortality, morbidity, and other outcomes in patients with acute gastrointestinal bleeding. The trial will enroll 8,000 patients from hospitals worldwide in a randomized, double-blind, placebo-controlled design comparing intravenous TXA to placebo. The primary outcome is death within 28 days. Secondary outcomes include rebleeding, need for intervention, transfusion requirements, thrombotic events, and other complications. If shown to be effective and safe, TXA could significantly impact the management of gastrointestinal bleeding globally.
Identifying High Performing Sites and Engaging Patients
One of the biggest challenges facing any clinical trial is how to identify the sites with the greatest potential to engage and retain patients. Applying decades of experience to the topic, Medpace experts will share considerations, lessons-learned and best practices for developing patient recruitment strategies to put you on the path for optimal success.
Knowledge Translation: Practical Strategies for Success v1
This document discusses knowledge translation (KT), which is the process of moving research findings and evidence into clinical practice. It provides an overview of KT and outlines a framework for conducting KT comprising 9 steps: 1) identifying a knowledge-practice gap; 2) measuring the magnitude and root cause; 3) forming a KT team; 4) finding and appraising the evidence; 5) assessing barriers; 6) adapting knowledge; 7) selecting and implementing interventions; 8) monitoring process and outcomes; and 9) sustaining improvements. The document then provides a practical example of using this framework to improve documentation of red flags for low back pain patient referrals to physical therapy.
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
This document summarizes a study on bibliometric trends in health economic evaluations in sub-Saharan Africa. The study analyzed 345 articles from the NHS EED database to characterize economic evaluations and examine collaboration patterns. It found that evaluations mostly addressed HIV, malaria, and tuberculosis, and focused on treatment interventions. While sub-Saharan authors frequently collaborated with other African researchers from their own country, collaboration between African countries was weaker than with the US and Europe. The study concludes collaboration across African countries should be promoted to support evidence-based decision making.
The power of study design 2014 10-27
Study design for laboratory developed tests (LDT) and in vitro diagnostics (IVD) can make or break product and business success. This top-down description of how to pick the right study design was delivered at the 5th Clinical Affairs & Regulatory Approvals For Diagnostics, October 27-29, 2014, in Alexandria, Virginia.
Enrolment of trial patients challenges & strategies
This document discusses challenges and strategies related to patient enrollment in clinical trials. It notes that successful trials require timely enrollment of the required number of patients with low dropout rates. Some key challenges to enrollment include understanding variability, risks related to costs and delays, and length of time needed for certain trials like cancer trials. Strategies discussed to improve enrollment include using various recruitment methods, understanding factors that affect time to completion, and developing a risk management plan. Barriers to enrollment include patient, physician, and cost-related factors. Successful enrollment requires identification and addressing of barriers at different stages of the recruitment process.
CED Tight Space Innovation Market Entry- final report
The document provides a summary of key findings from qualitative research conducted with 26 Key Opinion Leaders (KOLs) regarding convection enhanced delivery (CED) systems. The KOLs discussed the pros and cons of existing CED approaches and alternatives, noting CED's advantages for infusion depth and coverage area but need for improved molecule selection. Real-time monitoring and MRI compatibility were identified as important needs. Challenges included controlling infusion and determining toxicity. Overall CED was viewed as an attractive delivery strategy for drugs and other agents to treat brain tumors and neurodegenerative diseases if these challenges could be addressed.
Public.Cdsc.Middleton
The Clinical Decision Support Consortium aims to advance clinical decision support through several research projects. The Consortium will assess, define, demonstrate, and evaluate best practices for clinical decision support across multiple healthcare settings and electronic health record platforms. Several research teams will focus on knowledge management, clinical guideline translation, decision support content development and delivery, and evaluating demonstrations of decision support. The goal is to improve healthcare quality by facilitating widespread use of evidence-based clinical decision support.
Let 1000 flowers bloom: Support for the current “system”
The current system for evidence assessment in the United States is uncoordinated, with no single agency setting priorities and different organizations having varying objectives. Several initiatives have evolved to fill needs, such as the Drug Effectiveness Review Project which conducts reviews for state Medicaid programs. Prioritizing topics for systematic reviews is important due to scarce resources but major increases in funding and capacity may diminish the importance of prioritization in the future. The measure of success for any prioritization scheme is its usefulness to its intended audience.
More Related Content
What's hot
Improving Methods and Processes for Assessing Codependent Technologies
Technologies that enhance the precision and effect of therapies can make a critical contribution to ensuring value for money and improving patient care. Methods and processes for assessing value, however, still are imperfect. This presentation reviews the challenges and identifies some approaches for meeting them.
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Solid protocol design is critical to clinical development. No matter how well executed a clinical study is, if the underlying design is flawed, it wasn’t worth doing. In this presentation, Dr. David Shoemaker, SVP R&D, and Dr. Karen Kesler, AVP Operations, will walk through the process of developing a protocol, explain the major considerations, and point out common mistakes and challenges.
Regulation reimbursement and evidence on NMT
This document discusses regulatory approval and reimbursement for new medical technologies. It notes challenges with rising costs and uncertainty of drug development. It describes expedited FDA pathways like Fast Track, Priority Review, and Breakthrough Therapy Designation. While approval and coverage don't always align, experiences with parallel FDA/CMS review and conditional approvals in Europe aim to better link evidence standards. Adaptive pathways could approve technologies for narrow uses with commitments for further study. The goal is improving development efficiency and patients' access to promising new options.
One size does not fit all unique study management challenges for diagnostic ...
When partnering with a CRO, diagnostic company needs are different from those of pharmaceutical and device companies. This presentation was delivered at Outsourcing in Clinical Trials West Coast 2015, February 3-4, Burlingame, California.
Secondary Evidence Based Medicine Rsources SC
This document provides information on secondary evidence-based medicine (EBM) resources and point-of-care tools. It discusses the hierarchy of levels of evidence and describes various pre-appraised systematic reviews and individual studies. Examples of highly referenced EBM textbooks and primary literature databases are given. Point-of-care resources and tools that can be used immediately with patients, such as EBM summaries and clinical decision support systems, are also described. Examples of specific point-of-care resources covering areas like systematic reviews, clinical pathways, calculators, and patient education materials are provided.
Dr. Davy Cheng
This document discusses strategies and best practices for adopting medical technology. It emphasizes the importance of health technology assessment (HTA) and knowledge translation (KT) in facilitating evidence-informed decision making. Key challenges include gaps between research evidence and clinical practice. Strategies proposed include creating timely evidence reviews, using frameworks like Know4Go to evaluate technologies based on criteria like effectiveness and costs, and developing institutional capacity for HTA-informed decisions. Local contextualization, collaboration, training, and clinician champions are seen as important for successful technology adoption.
Major healthcare delivery trends 2015
The document discusses several secular trends in healthcare, including the shift towards value-based reimbursement models, increasing consumerism, and rapid advancements in technology and use of big data. Major trends include growing consolidation across healthcare sectors, 50% of Medicare payments transitioning to value-based models by 2018, a large increase in high deductible health plans, and billions in investments in digital health, technology, and analytics.
Clinical trial recruitment overview
- Patient recruitment for clinical trials is a major challenge, estimated to be a $1.2-1.8 billion market. Recruitment costs average 6% of trial costs and are a primary factor in delays.
- Less than 5% of patients are aware of clinical trials, and only 2-3% actually enroll. However, over 90% of participants have a positive experience and would participate again.
- There is significant opportunity to improve recruitment through more patient-centric approaches leveraging data, technology, and analytics to identify more eligible patients and improve the recruitment process. However, this will require changes to traditional models.
Patient recruitment
Patient recruitment and retention in clinical trials is recognized as a major challenge. Over 80% of trials fail to enroll on time due to difficulties recruiting the required number of suitable patients. Recruitment strategies are often not considered early enough in the trial planning process. Effective recruitment requires realistic timelines, adequate budgets, and the use of multiple recruitment methods like investigator databases, clinician referrals, advertisements, and community outreach. Maintaining open communication with patients and providing convenience are important for retention. Recent approaches to improve recruitment include using professional recruitment providers, market research, informatics, and centralized recruiting systems.
In with the old, out with the new
‘In with the old, out with the new’ – In search of ways to help health economists break their addiction to technology adoption. CHE Seminar presented by Professor Stirling Bryan, Director, Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute, Professor, School of Population & Public Health, University of British Columbia. 17th October 2014
Patient Recruitment Insights
A presentation showcasing some of the patient recruitment challenges that I encountered as a recruitment manager as well as some of the strategies -- DIGITAL ADVERTISING -- I used to overcome them.
Knowledge transfer, and evidence informed health policy-minster's meeting
This document discusses knowledge transfer between researchers and policymakers. It begins with an overview of the knowledge cycle and evidence-based healthcare. It notes that while researchers seek truth and policymakers seek compromise, their common goal is improving public health. The document recommends establishing units to facilitate knowledge transfer and decision support. It also suggests training policymakers to identify how research can help and accessing evidence to inform decisions. The overall message is that researchers and policymakers must understand each other and work together toward their shared goal of improving health outcomes.
Clinical Trial Recruitment & Retention
Patient recruitment & retention is highlighted as the key factor in ensuring study success, the area of patient retention in clinical trials is often overlooked. Retention of patients throughout the life of a clinical trial is however extremely vital from scientific as well as economic point of view. Poor recruitment & retention negatively impacts on the overall evaluable data for regulatory submissions. Dropped participants must be replaced which incurs further expenditures and time delays. Subject dropout rates are estimated to range from 15-40% of enrolled participants in clinical trials.
1-Halt-it Protocol International v1.0 26nov12
This document outlines the protocol for the HALT-IT clinical trial, which will determine the effects of tranexamic acid (TXA) on mortality, morbidity, and other outcomes in patients with acute gastrointestinal bleeding. The trial will enroll 8,000 patients from hospitals worldwide in a randomized, double-blind, placebo-controlled design comparing intravenous TXA to placebo. The primary outcome is death within 28 days. Secondary outcomes include rebleeding, need for intervention, transfusion requirements, thrombotic events, and other complications. If shown to be effective and safe, TXA could significantly impact the management of gastrointestinal bleeding globally.
Identifying High Performing Sites and Engaging Patients
One of the biggest challenges facing any clinical trial is how to identify the sites with the greatest potential to engage and retain patients. Applying decades of experience to the topic, Medpace experts will share considerations, lessons-learned and best practices for developing patient recruitment strategies to put you on the path for optimal success.
Knowledge Translation: Practical Strategies for Success v1
This document discusses knowledge translation (KT), which is the process of moving research findings and evidence into clinical practice. It provides an overview of KT and outlines a framework for conducting KT comprising 9 steps: 1) identifying a knowledge-practice gap; 2) measuring the magnitude and root cause; 3) forming a KT team; 4) finding and appraising the evidence; 5) assessing barriers; 6) adapting knowledge; 7) selecting and implementing interventions; 8) monitoring process and outcomes; and 9) sustaining improvements. The document then provides a practical example of using this framework to improve documentation of red flags for low back pain patient referrals to physical therapy.
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
This document summarizes a study on bibliometric trends in health economic evaluations in sub-Saharan Africa. The study analyzed 345 articles from the NHS EED database to characterize economic evaluations and examine collaboration patterns. It found that evaluations mostly addressed HIV, malaria, and tuberculosis, and focused on treatment interventions. While sub-Saharan authors frequently collaborated with other African researchers from their own country, collaboration between African countries was weaker than with the US and Europe. The study concludes collaboration across African countries should be promoted to support evidence-based decision making.
The power of study design 2014 10-27
Study design for laboratory developed tests (LDT) and in vitro diagnostics (IVD) can make or break product and business success. This top-down description of how to pick the right study design was delivered at the 5th Clinical Affairs & Regulatory Approvals For Diagnostics, October 27-29, 2014, in Alexandria, Virginia.
Enrolment of trial patients challenges & strategies
This document discusses challenges and strategies related to patient enrollment in clinical trials. It notes that successful trials require timely enrollment of the required number of patients with low dropout rates. Some key challenges to enrollment include understanding variability, risks related to costs and delays, and length of time needed for certain trials like cancer trials. Strategies discussed to improve enrollment include using various recruitment methods, understanding factors that affect time to completion, and developing a risk management plan. Barriers to enrollment include patient, physician, and cost-related factors. Successful enrollment requires identification and addressing of barriers at different stages of the recruitment process.
What's hot (19)
Improving Methods and Processes for Assessing Codependent Technologies
Improving Methods and Processes for Assessing Codependent Technologies
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
Protocol Design & Development: What You Need to Know to Ensure a Successful S...
One size does not fit all unique study management challenges for diagnostic ...
One size does not fit all unique study management challenges for diagnostic ...
Knowledge transfer, and evidence informed health policy-minster's meeting
Knowledge transfer, and evidence informed health policy-minster's meeting
Identifying High Performing Sites and Engaging Patients
Identifying High Performing Sites and Engaging Patients
Knowledge Translation: Practical Strategies for Success v1
Knowledge Translation: Practical Strategies for Success v1
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
Enrolment of trial patients challenges & strategies
Enrolment of trial patients challenges & strategies
Similar to Priority Setting for Comparative Effectiveness Research
CED Tight Space Innovation Market Entry- final report
The document provides a summary of key findings from qualitative research conducted with 26 Key Opinion Leaders (KOLs) regarding convection enhanced delivery (CED) systems. The KOLs discussed the pros and cons of existing CED approaches and alternatives, noting CED's advantages for infusion depth and coverage area but need for improved molecule selection. Real-time monitoring and MRI compatibility were identified as important needs. Challenges included controlling infusion and determining toxicity. Overall CED was viewed as an attractive delivery strategy for drugs and other agents to treat brain tumors and neurodegenerative diseases if these challenges could be addressed.
Public.Cdsc.Middleton
The Clinical Decision Support Consortium aims to advance clinical decision support through several research projects. The Consortium will assess, define, demonstrate, and evaluate best practices for clinical decision support across multiple healthcare settings and electronic health record platforms. Several research teams will focus on knowledge management, clinical guideline translation, decision support content development and delivery, and evaluating demonstrations of decision support. The goal is to improve healthcare quality by facilitating widespread use of evidence-based clinical decision support.
Let 1000 flowers bloom: Support for the current “system”
The current system for evidence assessment in the United States is uncoordinated, with no single agency setting priorities and different organizations having varying objectives. Several initiatives have evolved to fill needs, such as the Drug Effectiveness Review Project which conducts reviews for state Medicaid programs. Prioritizing topics for systematic reviews is important due to scarce resources but major increases in funding and capacity may diminish the importance of prioritization in the future. The measure of success for any prioritization scheme is its usefulness to its intended audience.
Board of Governors Meeting Denver, CO
The executive director provided an update on the activities and achievements of the Patient-Centered Outcomes Research Institute (PCORI) over the past few months. Key points included funding 50 pilot projects totaling $30.8 million to engage patients and stakeholders in research, finalizing the national research agenda, and relocating to a new office in Washington, D.C. The methodology committee delivered its first report on methodological standards for patient-centered outcomes research and plans to seek public comment on the report over the next few months before presenting it for board approval.
Plenary Day 1 Speaker 1 Hal Sox
The document summarizes the recommendations of an IOM committee on establishing a national program for clinical effectiveness research. The committee recommended designating a single entity to produce credible, unbiased information through systematic reviews and practice guidelines developed according to standard processes. This entity would set research priorities according to criteria like improving health outcomes and reducing disease burden. The committee proposed a hybrid model where this entity develops standards but existing groups conduct reviews, to reduce duplication and engender trust.
Research Ethics Committees (RECs- IRBs)
This document discusses the roles and functions of research ethics committees (RECs) and institutional review boards (IRBs). It provides an overview of when REC/IRB approval is required, the review process, and composition of RECs/IRBs. It also discusses interactions between IRBs in different countries and the roles of data safety monitoring boards. The document is authored by Dr. Tamer Hifnawy, an associate professor of public health in Egypt and Saudi Arabia who trains others in international research ethics.
Clinical trail protocol and development
The document provides guidelines for writing clinical trial protocols in India. It discusses that clinical trials prospectively assign human participants to health interventions to evaluate outcomes. A good protocol includes the study rationale, objectives, design, safety measures, and plans for statistical analysis and protecting human subjects. The protocol sections provide all relevant details about conducting the trial while meeting regulatory and ethical standards.
Dr. Andy Lee
This document discusses current and future innovation in the pharmaceutical industry from the perspective of Merck Research Laboratories. It outlines Merck's strategy to discover, develop, and bring innovative medicines to market by pursuing promising science, prioritizing key opportunities, and adapting to a changing landscape. Statistics are provided on Merck's 2018 clinical trial operations, and the relationships between product development teams, clinical sub-teams, and clinical trial teams. Considerations for clinical trial planning, site selection, and protocol design are examined. Pembrolizumab clinical development across many tumor types is reviewed, as are challenges developing a treatment for all genotypes of Hepatitis C.
REG Committee Meeting 26/09/15
This document summarizes the agenda and key discussion points for several committee meetings taking place on September 26th in Amsterdam. The Research Review committee will discuss priorities for funding respiratory research studies in 2015/2016. They will also evaluate the process for soliciting and reviewing research ideas. The Accreditation committee will discuss accrediting researchers. The Manuscript Review committee will examine their publication process and output over the past year. Overall, the meetings aim to strategize how the organization can best support high-quality respiratory research through prioritizing ideas, funding studies, and disseminating results.
Operations research within UK healthcare: A review
The paper "Operations research within UK healthcare: a review" provides an overview of the application of operations research (OR) in the UK healthcare sector. The review highlights the contribution of OR in improving efficiency, reducing costs, and enhancing patient outcomes in various areas of healthcare, such as hospital management, patient flow, resource allocation, and scheduling. The paper also discusses the challenges and opportunities in applying OR in healthcare, such as data availability, ethical considerations, and stakeholder engagement. Overall, the review provides insights into the potential of OR to drive innovation and improve healthcare delivery in the UK.
GPC Treatment Switching in Oncology Trials Initiative Overview
This document summarizes a project by the Green Park Collaborative to develop guidance on clinical drug trials in oncology where high rates of treatment switching are expected. The project brought together stakeholders from payers, regulatory agencies, universities, and patient groups. Through literature reviews, interviews, and workshops, they developed 18 recommendations across 5 areas to help ensure trials with treatment switching can still generate valid evidence for decision-makers. The final guidance document was released in October 2016.
Critical Path Initiative Challenges
The document discusses the FDA's Critical Path Initiative, which aims to improve the process of drug development and evaluation. It notes that the current drug development process is becoming a bottleneck. The initiative seeks to identify specific projects through a science-driven, shared effort between stakeholders to improve efficiency. The FDA must lead efforts to question assumptions that slow new product development and identify more efficient alternatives. The document also discusses two proposed projects - to create a "current state" process map to identify opportunities for improvement, and to develop a knowledge management system using ICH Q8 to ensure appropriate connectivity between all regulatory disciplines involved in drug development and review.
PCORI Methodology Committee Report
The document summarizes a webinar presented by the Patient-Centered Outcomes Research Institute's (PCORI) Methodology Committee on setting standards for research methods. The webinar covered the committee's mission to define methodological standards, discussed key topics in the committee's draft report including selecting research methods and developing standards, and took questions from webinar participants.
Comparative Effectiveness Research:: Threat or Opportunity
Comparative effectiveness research (CER) aims to compare different treatment options for health conditions. While controversial, CER has long been conducted by government agencies and is integral to regulatory approval processes. Recent healthcare reforms have significantly increased funding for CER through the Patient-Centered Outcomes Research Institute and require dissemination of findings. However, limitations remain on how findings can directly influence coverage and clinical practice may be slow to change. If conducted rigorously and findings are well-communicated, CER has potential to improve health outcomes and lower costs over time by informing treatment choices.
Designing of clinical study documentation -protocol and crf
The document discusses guidelines for designing clinical study documentation, including protocols and case report forms (CRFs). It provides details on establishing master files, protocol contents such as objectives, design, endpoints, and statistical analysis plans. It also covers CRF design, including formatting, instructions, question types, and procedures for corrections. The goal is to create documentation that clearly conveys all study details and collects comprehensive and accurate patient data to allow for analysis and regulatory review.
Comparative Effectiveness Research
Presentation on Comparative Effectiveness Research at University of Tennessee, Knoxville, September 2, 2010
COAs Science application at Early Stages of Drug Development
COAs Science application at Early Stages of Drug Development Neuropsychological Research Organization s.l
A view of COAs Science application at Early Stages of Drug Development - 10 Basic Steps, by Silvia Zaragoza Domingo, MA, PhD.
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
The appropriate ordering project uses data extracted from Electronic Medical Record to create dashboards to inform and engage clinicians in ordering practices. This presentation looks at the techniques used to create answers for the clinicians questions and discusses the purpose behind 12 dashboards. It looks at the change management approaches and challenges.
The initial pilot project has been embraced by a number of local health districts in NSW and templates have been made available along with training tools.
From professional standards to information standards
Anne Casey RN MSc FRCN
Editor, Paediatric Nursing
Royal College of Nursing Adviser on Information Standards
Clinical Domain Lead, NHS Information Standards Board for Health and Social Care
(17/10/08, Plenary session 2)
Systematic Review of CoPs in surgery
The document discusses quality improvement (QI) projects in surgery using communities of practice. It identifies key elements that enable successful QI projects including leadership support, resources, skills/tools for implementing changes, and overcoming barriers such as lack of training, ownership issues, and sustainability challenges. Examples are provided of regional QI projects in various locations that utilized strategies like physician leaders, benchmarking, and data registries.
Similar to Priority Setting for Comparative Effectiveness Research (20)
CED Tight Space Innovation Market Entry- final report
CED Tight Space Innovation Market Entry- final report
Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”
Operations research within UK healthcare: A review
Operations research within UK healthcare: A review
GPC Treatment Switching in Oncology Trials Initiative Overview
GPC Treatment Switching in Oncology Trials Initiative Overview
Comparative Effectiveness Research:: Threat or Opportunity
Comparative Effectiveness Research:: Threat or Opportunity
Designing of clinical study documentation -protocol and crf
Designing of clinical study documentation -protocol and crf
COAs Science application at Early Stages of Drug Development
COAs Science application at Early Stages of Drug Development
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
Ronan Herlihy on Engaging Clinicians with data on their ordering practices
From professional standards to information standards
From professional standards to information standards
More from Leonard Davis Institute of Health Economics
The Effects of Federal Parity on Substance Use Disorder Treatment_Andrew Epst...
The Effects of Federal Parity on Substance Use Disorder Treatment_Andrew Epst...Leonard Davis Institute of Health Economics
This study analyzed insurance claims data from before and after the implementation of the Federal Mental Health Parity and Addiction Equity Act to examine the effects of parity on substance use disorder treatment. The results showed:
1) There was no change in the use of substance use disorder services or the total annual spending per enrollee on these services (which increased by only $10 per enrollee).
2) There was also no change in out-of-pocket spending for substance use disorder treatment users or several HEDIS quality measures related to identification and initiation of treatment.
3) This suggests that concerns about parity greatly increasing health care costs related to substance use disorder treatment were unfounded.Epstein,andy ispor poster_2013
This study analyzed insurance claims data from before and after the implementation of the Federal Mental Health Parity and Addiction Equity Act to examine the effects of parity on substance use disorder treatment. The results showed:
1) There was no change in the use of substance use disorder services or the total annual spending per enrollee on these services (which increased by only $10 per enrollee).
2) There was also no change in out-of-pocket spending for substance use disorder treatment users or several HEDIS quality measures related to identification and initiation of treatment.
3) This suggests that concerns about parity greatly increasing health care costs related to substance use disorder treatment were unfounded.
Does a Wireless Incentive Structure Improve Retention, Subject Satisfaction a...
Does a Wireless Incentive Structure Improve Retention, Subject Satisfaction a...Leonard Davis Institute of Health Economics
This study compared retention rates, satisfaction, and safety between intimate partner violence (IPV) research participants paid via wireless gift cards versus cash. Participants receiving gift cards completed significantly more of the 12 weekly phone surveys (average 8.3 vs 6 calls). Over 90% of gift card recipients expressed satisfaction, and 60% preferred this method. While safety did not differ, wireless incentives may improve retention in repetitive IPV research that can involve remote data collection.Characterizing Emergency Department Utilization By A Population-based Cohort...
Characterizing Emergency Department Utilization By A Population-based Cohort...Leonard Davis Institute of Health Economics
This study analyzed data from 658 insured pregnant women in a Midwestern county to compare risks and outcomes between those who did and did not utilize the emergency department (ED) during their peripartum period. The study found that 218 women (33%) visited the ED at least once during this time. ED users were more likely to experience psychosocial risks like postpartum depression and smoking, have poorer birth outcomes like prematurity, and have inadequate prenatal care. After adjusting for demographic factors, ED use was associated with a higher likelihood of postpartum depression, smoking during pregnancy, unstable housing, delayed prenatal care initiation, and missing a postpartum visit.Non-Medically Indicated Delivery Prior to 39 Weeks Gestation in United State...
Non-Medically Indicated Delivery Prior to 39 Weeks Gestation in United State...Leonard Davis Institute of Health Economics
This study conducted a telephone survey of labor and delivery units at U.S. hospitals to determine the prevalence of hospital policies addressing non-medically indicated deliveries prior to 39 weeks gestation. They found that 66.5% of responding hospitals reported having such a policy. Hospitals in states with initiatives to reduce early deliveries were more likely to have a policy, with 67.8% of hospitals in initiative states reporting a policy compared to 62.1% in non-initiative states. The majority (68.8%) of policies were coded as having a "hard stop" against early deliveries. The study concludes that state initiatives can effectively encourage more hospitals to adopt restrictive policies on non-medically indicated early deliverA Qualitative Study of Adverse Childhood Experiences of Low-Income Youth in P...
A Qualitative Study of Adverse Childhood Experiences of Low-Income Youth in P...Leonard Davis Institute of Health Economics
This study explored a broader range of adverse childhood experiences reported by low-income adults from Philadelphia compared to those measured in previous research. The researchers conducted focus groups with 119 participants who generated a list of childhood stressors across 10 domains. The most commonly reported experiences were issues within family relationships, community safety threats, personal victimization, and economic hardship. The study concludes that considering a wider range of adversities is important for understanding health impacts on low-income urban populations.The Intersection of Attitudes and Organizational Factors by Provider Type in ...
The Intersection of Attitudes and Organizational Factors by Provider Type in ...Leonard Davis Institute of Health Economics
This document summarizes a mixed-methods study examining the relationship between mental health therapists' attitudes towards evidence-based practices (EBPs), perceptions of organizational factors, and degree status. The study found that doctoral-level therapists with positive attitudes reported more autonomy, while those with less positive attitudes reported requirements to use CBT and lack of time. Non-doctoral therapists reported lack of resources, space, funding, and regular client access as barriers. Managerial support was a facilitator for all therapists. The study provides insight into implementation challenges faced in community clinics from front-line perspectives.Doulas to fill the gap: a proposed model of doula delivery of cognitive-behav...
Doulas to fill the gap: a proposed model of doula delivery of cognitive-behav...Leonard Davis Institute of Health Economics
This document proposes a model where doulas receive training in cognitive behavioral therapy (CBT) principles from staff at an integrated maternal wellness clinic. The objectives are to incorporate doulas into standard practice while providing training, and to utilize doulas to increase implementation of evidence-based CBT for common mental health issues in the perinatal period like anxiety and depression. Limitations include challenges of implementing a novel intervention and ensuring standardized training, protected staff time, and adherence to practice guidelines.A Glorious Mess: Implementing Evidence-Based Social Skills Interventions in P...
A Glorious Mess: Implementing Evidence-Based Social Skills Interventions in P...Leonard Davis Institute of Health Economics
This study piloted a modified social skills intervention for children with ASD implemented by school personnel in public school settings. The intervention focused on facilitating peer engagement during lunch and recess. Results showed improvements in social network centrality and joint engagement for children who received the immediate treatment compared to those in the waitlist control. However, barriers like unclear staff roles, lack of support, and loss of recess time prevented long-term sustainability. Future work is needed to address school-level barriers to implementation and adapt interventions to fit individual school contexts.Healthcare System Supports for Internists Caring for Young Adult Patients wit...
Healthcare System Supports for Internists Caring for Young Adult Patients wit...Leonard Davis Institute of Health Economics
This study examined the healthcare system supports for internists caring for young adult patients with chronic illnesses that began in pediatric care. Semi-structured interviews were conducted with 21 internists across 4 states. The interviews identified 5 major themes of healthcare system burdens experienced by internists, including difficulty identifying patients' medical teams, inadequate time for complex patients, significant administrative burden, lack of social/case management support, and financial constraints. The interviews also identified 3 potential strategies to improve supports, such as formalizing transfer processes, maximizing electronic records/communication, and leveraging patient-centered medical homes and bundled payments.Elderly Adults with Dementia and Young Adults with Developmental Disabilities...
Elderly Adults with Dementia and Young Adults with Developmental Disabilities...Leonard Davis Institute of Health Economics
Most internists found more similarities than differences in caring for young adults with intellectual and developmental disabilities (I/DD) and elderly adults with dementia. Both populations require longer office visits and more staffing resources due to complex health histories. Obtaining records and coordinating care can be difficult for both. Reliance on advocates, community services for transportation and supervision, and vulnerability to insurance changes are also similarities. While specific diseases differ, models for geriatric care could potentially address supervision and caretaking needs for adults with I/DD. Strengthening safety net services would help low-income families and elderly patients with dementia or I/DD.Is the quality of case management in a medical home associated with patient s...
Is the quality of case management in a medical home associated with patient s...Leonard Davis Institute of Health Economics
This study examines the association between patient perceptions of case manager performance and satisfaction with care, as well as the relationship between perceptions of case managers and primary care providers (PCPs) and subsequent healthcare utilization. The study analyzed survey and claims data from over 2,000 patients receiving primary care from a medical home model with embedded case managers. The results found that higher ratings of both case manager and PCP performance were independently associated with greater patient satisfaction. The study concludes by noting that perceptions of case management may impact health outcomes and behaviors, warranting further analysis of utilization patterns.Comparison of HIV Testing with other Markers of Chronic Disease Screening 4_...
Comparison of HIV Testing with other Markers of Chronic Disease Screening 4_...Leonard Davis Institute of Health Economics
This document analyzes survey data from 2002-2010 on HIV testing rates and chronic disease screening in Southeastern Pennsylvania. It finds that HIV testing rates are lower than screening for other chronic diseases. Populations receiving care at community health clinics, emergency rooms, or with no primary care are more likely to get HIV testing than those at private clinics. While community health clinics perform similar to private clinics on chronic disease screening, those using emergency rooms or with no primary care are less likely to receive routine chronic disease screening. Primary care physicians adhere to guidelines for screening of conditions like blood pressure and cancer but may neglect appropriately screening for HIV.Comparison of HIV Testing with other Markers of Chronic Disease Screening
Comparison of HIV Testing with other Markers of Chronic Disease Screening Leonard Davis Institute of Health Economics
This study analyzed survey data from 50,698 individuals in Southeastern Pennsylvania between 2002-2010 to compare HIV testing rates to other routine health screenings. It found that HIV testing rates were lower than for other conditions. Those receiving care at community health clinics, emergency rooms, or with no primary care had higher odds of receiving an HIV test compared to private clinics. While community health clinics performed similarly to private clinics on other screenings, emergency rooms and no primary care had lower rates. The study suggests primary care physicians may neglect appropriate HIV screening of patients despite adhering to other screening guidelines.High Value Cost Conscious Care: Is it Rationing or Rational Care? 1_11_13
High Value Cost Conscious Care: Is it Rationing or Rational Care? 1_11_13Leonard Davis Institute of Health Economics
1. The document discusses high value cost conscious care and whether it constitutes rationing or rational care.
2. It notes that health care costs in the US continue to rise significantly each year, with diagnostic imaging being a major driver of increasing costs.
3. Data from 6 large health systems showed large variations in diagnostic imaging rates between different regions without clear clinical benefits, indicating opportunities for more rational use of imaging to improve quality and reduce costs.LDI Research Seminar with Art Kellermann, MD, MPH 11_28_12
LDI Research Seminar with Art Kellermann, MD, MPH 11_28_12Leonard Davis Institute of Health Economics
This document summarizes key findings from RAND research on health care spending in the United States. It finds that between 1999-2009, health care costs grew substantially for a median-income American family, consuming money that could have otherwise been used to pay down debt, save for retirement, or pay for education. While Americans received more medical services, the quality of care was still suboptimal, with recommended care received only about 55% of the time. The document also examines different approaches to reducing health care costs, finding that high-deductible health plans with deductibles over $1,000 were effective in reducing spending.CMHPSR/LDI Research Seminar_New Models for Childrens Mental Health Services D...
CMHPSR/LDI Research Seminar_New Models for Childrens Mental Health Services D...Leonard Davis Institute of Health Economics
The document outlines Marc Atkins' presentation goals which include reviewing concerns with the current U.S. children's mental health care system, justifying a focus on schooling using ecological principles and a public health framework, presenting an experimental intervention model and preliminary results, and discussing future directions. It then lists the collaborators involved in the research from various universities.LDI Research Seminar 9_7_12 Eff ects of Federal Policy to Insure Young Adults...
LDI Research Seminar 9_7_12 Eff ects of Federal Policy to Insure Young Adults...Leonard Davis Institute of Health Economics
The document summarizes a study that analyzes the effects of the 2010 Affordable Care Act's dependent coverage mandate on young adults' health insurance coverage and labor market behavior using data from the 2008 panel of the Survey of Income and Program Participation. The study finds that the policy led to a 3.3 percentage point reduction in uninsurance among young adults ages 19-25, a 6.2 percentage point increase in dependent coverage through a parent's employer-sponsored insurance, and evidence of increased labor market flexibility for young adults.LDI Poster Template
This document provides a template for creating scientific posters. It includes suggestions for formatting, design principles, and sections like the title, abstract, methods, results, and conclusions. The template is meant to simplify poster creation and emphasize key points for viewers through techniques like italics, boldface, and effective use of space. Proper formatting of images, tables, and graphs is also discussed. The goal is to design posters that are easy to understand and focused on the needs of the audience.
LDI Charles Leighton Memorial Lecture with Mark Chassin, MD 5_4_12
LDI Charles Leighton Memorial Lecture with Mark Chassin, MD 5_4_12Leonard Davis Institute of Health Economics
1) Current state of quality and safety in healthcare is poor, with routine safety processes failing regularly and preventable adverse events occurring commonly.
2) High reliability organizations like commercial aviation have achieved much higher levels of safety through effective process improvement, a strong safety culture, and principles of collective mindfulness.
3) The Joint Commission aims to transform healthcare into a high reliability industry through initiatives like robust quality measurement, establishing accountability criteria for measures, and promoting high reliability principles.More from Leonard Davis Institute of Health Economics (20)
The Effects of Federal Parity on Substance Use Disorder Treatment_Andrew Epst...
The Effects of Federal Parity on Substance Use Disorder Treatment_Andrew Epst...
Does a Wireless Incentive Structure Improve Retention, Subject Satisfaction a...
Does a Wireless Incentive Structure Improve Retention, Subject Satisfaction a...
Characterizing Emergency Department Utilization By A Population-based Cohort...
Characterizing Emergency Department Utilization By A Population-based Cohort...
Non-Medically Indicated Delivery Prior to 39 Weeks Gestation in United State...
Non-Medically Indicated Delivery Prior to 39 Weeks Gestation in United State...
A Qualitative Study of Adverse Childhood Experiences of Low-Income Youth in P...
A Qualitative Study of Adverse Childhood Experiences of Low-Income Youth in P...
The Intersection of Attitudes and Organizational Factors by Provider Type in ...
The Intersection of Attitudes and Organizational Factors by Provider Type in ...
Doulas to fill the gap: a proposed model of doula delivery of cognitive-behav...
Doulas to fill the gap: a proposed model of doula delivery of cognitive-behav...
A Glorious Mess: Implementing Evidence-Based Social Skills Interventions in P...
A Glorious Mess: Implementing Evidence-Based Social Skills Interventions in P...
Healthcare System Supports for Internists Caring for Young Adult Patients wit...
Healthcare System Supports for Internists Caring for Young Adult Patients wit...
Elderly Adults with Dementia and Young Adults with Developmental Disabilities...
Elderly Adults with Dementia and Young Adults with Developmental Disabilities...
Is the quality of case management in a medical home associated with patient s...
Is the quality of case management in a medical home associated with patient s...
Comparison of HIV Testing with other Markers of Chronic Disease Screening 4_...
Comparison of HIV Testing with other Markers of Chronic Disease Screening 4_...
Comparison of HIV Testing with other Markers of Chronic Disease Screening
Comparison of HIV Testing with other Markers of Chronic Disease Screening
High Value Cost Conscious Care: Is it Rationing or Rational Care? 1_11_13
High Value Cost Conscious Care: Is it Rationing or Rational Care? 1_11_13
LDI Research Seminar with Art Kellermann, MD, MPH 11_28_12
LDI Research Seminar with Art Kellermann, MD, MPH 11_28_12
CMHPSR/LDI Research Seminar_New Models for Childrens Mental Health Services D...
CMHPSR/LDI Research Seminar_New Models for Childrens Mental Health Services D...
LDI Research Seminar 9_7_12 Eff ects of Federal Policy to Insure Young Adults...
LDI Research Seminar 9_7_12 Eff ects of Federal Policy to Insure Young Adults...
LDI Charles Leighton Memorial Lecture with Mark Chassin, MD 5_4_12
LDI Charles Leighton Memorial Lecture with Mark Chassin, MD 5_4_12
Recently uploaded
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
cosmetics and cosmeceuticals
Muskan
mpharm
2nd semester
Guru Gobind Singh college of pharmacy, yamunanagar, haryana
PGx Analysis in VarSeq: A User’s Perspective
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
5 Effective Homeopathic Medicines for Irregular Periods
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montrealGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Foundation of Yoga, YCB Level-3, Unit-1
Unit -1 of Yoga certification board, level 3, all topics covered. An exam conducted by ministry of Ayush for yoga enthusiastic students.
Pharmacology of 5-hydroxytryptamine and Antagonist
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
How to choose the best dermatologists in Indore.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...ayushrajshrivastava7
Regulatory Affairs
Full hand written notes
M.pharm - 1st year .Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
Recently uploaded (20)
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Full Handwritten notes of RA by Ayush Kumar M pharm - Al ameen college of pha...
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.